BGM Group (BGM) Competitors $10.18 -0.65 (-6.00%) Closing price 04:00 PM EasternExtended Trading$10.24 +0.05 (+0.54%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BGM vs. SRRK, AMRX, HCM, APLS, MOR, RARE, CNTA, XENE, CGON, and NAMSShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Scholar Rock (SRRK), Amneal Pharmaceuticals (AMRX), HUTCHMED (HCM), Apellis Pharmaceuticals (APLS), MorphoSys (MOR), Ultragenyx Pharmaceutical (RARE), Centessa Pharmaceuticals (CNTA), Xenon Pharmaceuticals (XENE), CG Oncology (CGON), and NewAmsterdam Pharma (NAMS). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Scholar Rock Amneal Pharmaceuticals HUTCHMED Apellis Pharmaceuticals MorphoSys Ultragenyx Pharmaceutical Centessa Pharmaceuticals Xenon Pharmaceuticals CG Oncology NewAmsterdam Pharma BGM Group (NASDAQ:BGM) and Scholar Rock (NASDAQ:SRRK) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Do analysts prefer BGM or SRRK? Scholar Rock has a consensus price target of $46.40, suggesting a potential upside of 34.53%. Given Scholar Rock's stronger consensus rating and higher probable upside, analysts clearly believe Scholar Rock is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Scholar Rock 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 3 Strong Buy rating(s) 3.23 Does the media refer more to BGM or SRRK? In the previous week, Scholar Rock had 47 more articles in the media than BGM Group. MarketBeat recorded 49 mentions for Scholar Rock and 2 mentions for BGM Group. BGM Group's average media sentiment score of 1.75 beat Scholar Rock's score of -0.08 indicating that BGM Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BGM Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Scholar Rock 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 8 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, BGM or SRRK? BGM Group has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Scholar Rock has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500. Is BGM or SRRK more profitable? BGM Group's return on equity of 0.00% beat Scholar Rock's return on equity.Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A Scholar Rock N/A -127.11%-90.09% Do institutionals and insiders have more ownership in BGM or SRRK? 91.1% of Scholar Rock shares are held by institutional investors. 58.7% of BGM Group shares are held by company insiders. Comparatively, 13.3% of Scholar Rock shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has higher earnings & valuation, BGM or SRRK? BGM Group has higher revenue and earnings than Scholar Rock. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$26.85M36.87-$1.44MN/AN/AScholar RockN/AN/A-$246.29M-$2.91-11.85 SummaryBGM Group beats Scholar Rock on 7 of the 13 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$989.72M$3.07B$5.65B$10.29BDividend YieldN/A2.36%5.68%4.61%P/E RatioN/A20.7975.8626.14Price / Sales36.87404.26515.95170.63Price / CashN/A45.9137.5661.52Price / Book1.399.6312.886.30Net Income-$1.44M-$52.73M$3.29B$271.03M7 Day Performance1.90%0.66%-0.24%-0.13%1 Month Performance26.77%6.33%3.87%6.43%1 Year Performance32.21%18.99%68.39%28.82% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM Group0.887 of 5 stars$10.18-6.0%N/A+36.6%$989.72M$26.85M0.00298News CoverageSRRKScholar Rock4.2863 of 5 stars$32.45-3.6%$46.33+42.8%+290.3%$3.12BN/A-11.15140Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst RevisionAMRXAmneal Pharmaceuticals3.1573 of 5 stars$9.72-0.8%$12.00+23.5%+15.0%$3.05B$2.79B972.478,100Positive NewsHCMHUTCHMED3.0258 of 5 stars$17.48-0.3%$28.00+60.2%-8.5%$3.05B$630.20M0.001,811Positive NewsAnalyst DowngradeAPLSApellis Pharmaceuticals4.1077 of 5 stars$23.73-2.7%$34.12+43.8%-26.0%$3.00B$754.65M-13.04770Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730RAREUltragenyx Pharmaceutical4.209 of 5 stars$29.46+1.6%$81.50+176.6%-50.0%$2.84B$560.23M-5.331,294Positive NewsCNTACentessa Pharmaceuticals3.1601 of 5 stars$21.08-4.3%$32.44+53.9%+54.4%$2.82B$6.85M-11.76200Insider TradeXENEXenon Pharmaceuticals2.5888 of 5 stars$35.97-0.1%$53.30+48.2%-6.0%$2.77B$7.50M-10.13210Positive NewsCGONCG Oncology2.4869 of 5 stars$36.25+4.8%$53.91+48.7%+0.4%$2.76B$551K-20.4861Insider TradeNAMSNewAmsterdam Pharma3.0821 of 5 stars$24.36+1.0%$41.55+70.6%+72.1%$2.75B$45.56M-15.064Positive News Related Companies and Tools Related Companies SRRK Competitors AMRX Competitors HCM Competitors APLS Competitors MOR Competitors RARE Competitors CNTA Competitors XENE Competitors CGON Competitors NAMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
